Advertisement
Screener

Pharming Group N.V. (PHAR) Form 6-K: Report of foreign private issuer, 2022

Pharming Group N.V. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-10-27: Form 6-K; Period of report 2022-10-27; Description 6-K; Document pharminggroupfinancialresu.htm.
  • 2022-08-04: Form 6-K; Period of report 2022-08-04; Description 6-K; Document h1pr2022.htm.
  • 2022-08-02: Form 6-K; Period of report 2022-08-02; Description 6-K; Document pharminggroupannouncesnewi.htm.
  • 2022-08-01: Form 6-K; Period of report 2022-08-01; Description 6-K; Document secfilingemaacceleratedass.htm.
FiledFormPeriod of reportDescriptionDocument
2022-10-276-K2022-10-276-Kpharminggroupfinancialresu.htm
2022-08-046-K2022-08-046-Kh1pr2022.htm
2022-08-026-K2022-08-026-Kpharminggroupannouncesnewi.htm
2022-08-016-K2022-08-016-Ksecfilingemaacceleratedass.htm
2022-06-026-K2022-06-026-Ka220602pharminggrouptopres.htm
2022-05-186-K2022-05-186-Kpharminggroupagm2022results.htm
2022-05-126-K2022-05-126-Ka6-kpressreleaseq12022.htm
2022-05-056-K2022-05-056-Kpharminggroupnoticeofq1202.htm
2022-04-266-K2022-04-266-Kpippimapprovalmhrauk.htm
2022-04-226-K2022-04-226-Kpharmingannounceschangeini.htm
2022-04-066-K2022-04-066-Kpharminggroupannouncesthep.htm
2022-04-016-K2022-04-016-Kpresentationofleniolisibda.htm
2022-03-176-K2022-03-176-Kpharminggroupfinancialresu.htm
2022-03-086-K2022-03-086-Kanalystcallwebinardetailsm.htm
2022-02-026-K2022-02-026-Kleniolisibtoplinephase23.htm
2022-01-066-K2022-01-066-Kpipapproval.htm
2022-01-046-K2021-12-236-Kstrategicmanufacturingagre.htm